EQUATE NTS

Equate Nts Adverse Events Reported to the FDA Over Time

How are Equate Nts adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Equate Nts, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Equate Nts is flagged as the suspect drug causing the adverse event.

Most Common Equate Nts Adverse Events Reported to the FDA

What are the most common Equate Nts adverse events reported to the FDA?

Application Site Pruritus	95 (7.54%)
Application Site Erythema	82 (6.51%)
Nausea	78 (6.19%)
Dizziness	56 (4.44%)
Application Site Irritation	54 (4.29%)
Nicotine Dependence	43 (3.41%)
Headache	31 (2.46%)
Drug Ineffective	28 (2.22%)
Abnormal Dreams	25 (1.98%)
Insomnia	25 (1.98%)
Pain In Extremity	23 (1.83%)
	Show More
Vomiting	22 (1.75%)
Application Site Pain	21 (1.67%)
Application Site Rash	20 (1.59%)
Application Site Reaction	20 (1.59%)
Heart Rate Increased	20 (1.59%)
Application Site Swelling	19 (1.51%)
Intentional Drug Misuse	19 (1.51%)
Malaise	17 (1.35%)
Nervousness	16 (1.27%)
Application Site Urticaria	15 (1.19%)
Asthenia	15 (1.19%)
Hypoaesthesia	15 (1.19%)
Rash	14 (1.11%)
Application Site Dermatitis	13 (1.03%)
Hypersensitivity	13 (1.03%)
Hyperhidrosis	12 (.95%)
Tremor	11 (.87%)
Anxiety	9 (.71%)
Feeling Abnormal	9 (.71%)
Pruritus	9 (.71%)
Blood Pressure Increased	8 (.63%)
Chest Pain	8 (.63%)
Feeling Hot	8 (.63%)
Feeling Jittery	8 (.63%)
Irritability	8 (.63%)
Nightmare	8 (.63%)
Application Site Warmth	7 (.56%)
Dysgeusia	7 (.56%)
Crying	6 (.48%)
Muscle Spasms	6 (.48%)
Myalgia	6 (.48%)
Palpitations	6 (.48%)
Pruritus Generalised	6 (.48%)
Application Site Discolouration	5 (.4%)
Application Site Papules	5 (.4%)
Application Site Vesicles	5 (.4%)
Convulsion	5 (.4%)
Diarrhoea	5 (.4%)
Dyspepsia	5 (.4%)
Fatigue	5 (.4%)
Migraine	5 (.4%)
Paraesthesia	5 (.4%)
Rash Generalised	5 (.4%)
Back Pain	4 (.32%)
Eructation	4 (.32%)
Erythema	4 (.32%)
Hot Flush	4 (.32%)
Hypertension	4 (.32%)
Oedema Peripheral	4 (.32%)
Poor Quality Sleep	4 (.32%)
Pyrexia	4 (.32%)
Urticaria	4 (.32%)
Abdominal Distension	3 (.24%)
Abdominal Pain Upper	3 (.24%)
Amenorrhoea	3 (.24%)
Application Site Burn	3 (.24%)
Application Site Discomfort	3 (.24%)
Application Site Dryness	3 (.24%)
Depression	3 (.24%)
Drug Abuser	3 (.24%)
Dry Skin	3 (.24%)
Dyspnoea	3 (.24%)
Gingival Swelling	3 (.24%)
Musculoskeletal Pain	3 (.24%)
Oral Discomfort	3 (.24%)
Restlessness	3 (.24%)
Salivary Hypersecretion	3 (.24%)
Speech Disorder	3 (.24%)
Throat Irritation	3 (.24%)
Vaginal Discharge	3 (.24%)
Vision Blurred	3 (.24%)
Abdominal Discomfort	2 (.16%)
Abdominal Pain	2 (.16%)
Anger	2 (.16%)
Application Site Paraesthesia	2 (.16%)
Burning Sensation	2 (.16%)
Burning Sensation Mucosal	2 (.16%)
Circulatory Collapse	2 (.16%)
Cough	2 (.16%)
Dissociation	2 (.16%)
Disturbance In Attention	2 (.16%)
Drug Administration Error	2 (.16%)
Drug Exposure During Pregnancy	2 (.16%)
Drug Interaction	2 (.16%)
Drug Level Decreased	2 (.16%)
Dry Mouth	2 (.16%)
Expired Drug Administered	2 (.16%)
Flatulence	2 (.16%)
Influenza	2 (.16%)
Influenza Like Illness	2 (.16%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Equate Nts, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equate Nts is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Equate Nts

What are the most common Equate Nts adverse events reported to the FDA?

Administration Site Reactions	374 (29.68%)
Gastrointestinal Signs	123 (9.76%)
Neurological	101 (8.02%)
Psychiatric	63 (5%)
Sleep Disorders	60 (4.76%)
Epidermal And Dermal Conditions	52 (4.13%)
Headaches	36 (2.86%)
Musculoskeletal And Connective Tiss...	35 (2.78%)
Cardiac And Vascular Investigations	30 (2.38%)
Therapeutic And Nontherapeutic Effe...	30 (2.38%)
Anxiety Disorders	28 (2.22%)
	Show More
Respiratory	16 (1.27%)
Movement Disorders	14 (1.11%)
Muscle	14 (1.11%)
Skin Appendage Conditions	14 (1.11%)
Allergic Conditions	13 (1.03%)
Oral Soft Tissue Conditions	13 (1.03%)
Medication Errors	8 (.63%)
Vascular	7 (.56%)
Cardiac Disorder Signs	6 (.48%)
Gastrointestinal Motility And Defec...	6 (.48%)
Mood Disorders	6 (.48%)
Dental And Gingival Conditions	5 (.4%)
Infections - Pathogen Unspecified	5 (.4%)
Salivary Gland Conditions	5 (.4%)
Seizures	5 (.4%)
Sleep Disturbances	5 (.4%)
Angiedema And Urticaria	4 (.32%)
Body Temperature Conditions	4 (.32%)
Bone Disorders	4 (.32%)
Depressed Mood Disorders	4 (.32%)
Vascular Hypertensive	4 (.32%)
Vision	4 (.32%)
Changes In Physical Activity	3 (.24%)
Eye	3 (.24%)
Inner Ear And Viiith Cranial Nerve	3 (.24%)
Lifestyle Issues	3 (.24%)
Menstrual Cycle And Uterine Bleedin...	3 (.24%)
Mental Impairment	3 (.24%)
Toxicology And Therapeutic Drug Mon...	3 (.24%)
Urinary Tract Signs	3 (.24%)
Vulvovaginal Disorders	3 (.24%)
Arteriosclerosis, Stenosis, Vascula...	2 (.16%)
Chemical Injury And Poisoning	2 (.16%)
Communication Disorders	2 (.16%)
Coronary Artery	2 (.16%)
Cranial Nerve Disorders	2 (.16%)
Decreased And Nonspecific Blood Pre...	2 (.16%)
Dissociative	2 (.16%)
Disturbances In Thinking	2 (.16%)
Head And Neck Therapeutic Procedure...	2 (.16%)
Ocular Sensory Symptoms	2 (.16%)
Physical Examination Topics	2 (.16%)
Suicidal And Self-injurious Behavio...	2 (.16%)
Viral Infectious	2 (.16%)
Appetite And General Nutritional	1 (.08%)
Bladder And Bladder Neck Disorders	1 (.08%)
Deliria	1 (.08%)
Eating Disorders	1 (.08%)
Fungal Infectious	1 (.08%)
Glucose Metabolism Disorders	1 (.08%)
Heart Failures	1 (.08%)
Injuries By Physical Agents	1 (.08%)
Joint	1 (.08%)
Metabolic, Nutritional And Blood Ga...	1 (.08%)
Renal And Urinary Tract Investigati...	1 (.08%)
Schizophrenia And Other Psychotic	1 (.08%)
Tongue Conditions	1 (.08%)
Upper Respiratory Tract Disorders	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Equate Nts, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Equate Nts is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.